Stock listing
Lang & Schwarz:A40LEL Grace Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Grace Therapeutics, Inc. · home listing NASDAQ:GRCE
Follow Grace Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:GRCE
$1.94 USD 0.00 (0.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GRCE
- Day range
- $1.87 – $1.98 USDOct 30, 2026
- Volume
- 85,938 sharesOct 30, 2026
- Market cap
- $40.81M USDAt the close on Oct 30, 2026 · price × 21.04M shares outstanding
- 52-week range
- $1.67 – $5.18 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $295,181 USDMedian day 98,600 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GRCE · Home | $1.94 USD | 0.00 (0.0%) | 85,938 | $1.95 | $1.98 | $1.87 | $1.94 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:GRCE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.94 | 0.00 | 0.0% | $1.95 | $1.98 | $1.87 | 85,938 | |
| $1.94 | -0.07 | -3.5% | $1.99 | $2.048 | $1.882 | 75,709 | |
| $2.01 | +0.14 | +7.5% | $1.87 | $2.01 | $1.87 | 164,507 | |
| $1.87 | +0.06 | +3.3% | $1.80 | $1.90 | $1.80 | 110,459 | |
| $1.81 | -0.12 | -6.2% | $1.97 | $1.99 | $1.67 | 468,914 | |
| $1.93 | +0.015 | +0.8% | $1.91 | $1.95 | $1.88 | 47,222 | |
| $1.915 | -0.055 | -2.8% | $1.91 | $1.93 | $1.87 | 97,096 | |
| $1.97 | -0.01 | -0.5% | $1.96 | $2.02 | $1.94 | 77,141 | |
| $1.98 | +0.10 | +5.3% | $1.90 | $2.07 | $1.89 | 94,407 | |
| $1.88 | -0.01 | -0.5% | $1.89 | $1.97 | $1.822 | 90,431 | |
| $1.89 | -0.06 | -3.1% | $1.97 | $2.03 | $1.85 | 168,700 | |
| $1.95 | +0.06 | +3.2% | $1.91 | $1.97 | $1.89 | 109,300 | |
| $1.89 | -0.10 | -5.0% | $1.97 | $2.01 | $1.85 | 177,900 | |
| $1.99 | -0.03 | -1.5% | $2.00 | $2.02 | $1.97 | 52,400 | |
| $2.02 | -0.06 | -2.9% | $2.02 | $2.06 | $1.98 | 49,600 | |
| $2.08 | +0.04 | +2.0% | $2.05 | $2.09 | $2.03 | 37,800 | |
| $2.04 | -0.06 | -2.9% | $2.05 | $2.07 | $2.00 | 52,600 | |
| $2.10 | +0.03 | +1.4% | $2.06 | $2.12 | $2.05 | 84,300 | |
| $2.07 | +0.01 | +0.5% | $2.08 | $2.14 | $2.05 | 110,300 | |
| $2.06 | -0.01 | -0.5% | $2.04 | $2.08 | $2.01 | 79,000 | |
| $2.07 | +0.03 | +1.5% | $2.04 | $2.07 | $2.00 | 105,000 | |
| $2.04 | -0.11 | -5.1% | $2.11 | $2.13 | $1.98 | 344,200 | |
| $2.15 | +0.04 | +1.9% | $2.14 | $2.16 | $2.10 | 25,300 | |
| $2.11 | -0.01 | -0.5% | $2.11 | $2.15 | $2.09 | 130,200 | |
| $2.12 | 0.00 | 0.0% | $2.12 | $2.14 | $2.09 | 58,700 | |
| $2.12 | -0.04 | -1.9% | $2.14 | $2.14 | $2.10 | 80,200 | |
| $2.16 | +0.04 | +1.9% | $2.17 | $2.18 | $2.09 | 106,300 | |
| $2.12 | -0.02 | -0.9% | $2.15 | $2.15 | $2.09 | 184,700 | |
| $2.14 | +0.04 | +1.9% | $2.09 | $2.17 | $2.08 | 70,100 | |
| $2.10 | -0.01 | -0.5% | $2.12 | $2.15 | $2.08 | 109,900 | |
| $2.11 | -0.02 | -0.9% | $2.14 | $2.17 | $2.10 | 83,700 | |
| $2.13 | -0.01 | -0.5% | $2.25 | $2.25 | $2.12 | 72,200 | |
| $2.14 | -0.09 | -4.0% | $2.23 | $2.24 | $2.14 | 65,500 | |
| $2.23 | -0.06 | -2.6% | $2.29 | $2.29 | $2.17 | 66,200 | |
| $2.29 | +0.07 | +3.2% | $2.21 | $2.32 | $2.21 | 48,300 | |
| $2.22 | -0.04 | -1.8% | $2.29 | $2.46 | $2.20 | 716,000 | |
| $2.26 | +0.12 | +5.6% | $2.24 | $2.31 | $2.20 | 397,500 | |
| $2.14 | +0.02 | +0.9% | $2.12 | $2.15 | $2.07 | 224,700 | |
| $2.12 | +0.02 | +1.0% | $2.09 | $2.14 | $2.05 | 159,500 | |
| $2.10 | -0.04 | -1.9% | $2.12 | $2.19 | $2.08 | 186,300 | |
| $2.14 | 0.00 | 0.0% | $2.15 | $2.20 | $2.07 | 159,200 | |
| $2.14 | +0.04 | +1.9% | $2.19 | $2.19 | $2.10 | 49,000 | |
| $2.10 | -0.03 | -1.4% | $2.09 | $2.14 | $2.07 | 77,700 | |
| $2.13 | +0.01 | +0.5% | $2.10 | $2.14 | $2.07 | 117,300 | |
| $2.12 | -0.04 | -1.9% | $2.16 | $2.16 | $2.12 | 66,100 | |
| $2.16 | +0.01 | +0.5% | $2.10 | $2.18 | $2.10 | 82,300 | |
| $2.15 | -0.05 | -2.3% | $2.20 | $2.20 | $2.14 | 22,200 | |
| $2.20 | +0.02 | +0.9% | $2.18 | $2.22 | $2.18 | 94,443 | |
| $2.18 | -0.02 | -0.9% | $2.23 | $2.23 | $2.13 | 86,601 | |
| $2.20 | +0.06 | +2.8% | $2.15 | $2.23 | $2.15 | 75,900 | |
| $2.14 | -0.06 | -2.7% | $2.19 | $2.24 | $2.10 | 54,700 | |
| $2.20 | +0.07 | +3.3% | $2.16 | $2.21 | $2.15 | 159,800 | |
| $2.13 | -0.03 | -1.4% | $2.17 | $2.17 | $2.04 | 103,900 | |
| $2.16 | 0.00 | 0.0% | $2.19 | $2.25 | $2.15 | 99,400 | |
| $2.16 | +0.09 | +4.3% | $2.06 | $2.19 | $2.02 | 397,800 | |
| $2.07 | -0.03 | -1.4% | $2.10 | $2.13 | $2.06 | 193,800 | |
| $2.10 | -0.02 | -0.9% | $2.13 | $2.13 | $2.06 | 121,800 | |
| $2.12 | +0.01 | +0.5% | $2.10 | $2.13 | $2.08 | 97,800 | |
| $2.11 | -0.02 | -0.9% | $2.13 | $2.16 | $2.08 | 184,300 | |
| $2.13 | +0.01 | +0.5% | $2.13 | $2.16 | $2.10 | 120,400 | |
| $2.12 | -0.02 | -0.9% | $2.14 | $2.25 | $2.08 | 162,700 | |
| $2.14 | -0.04 | -1.8% | $2.19 | $2.23 | $2.08 | 649,100 | |
| $2.18 | +0.10 | +4.8% | $2.09 | $2.18 | $2.07 | 100,500 | |
| $2.08 | 0.00 | 0.0% | $2.13 | $2.14 | $2.08 | 96,000 | |
| $2.08 | +0.01 | +0.5% | $2.10 | $2.17 | $2.03 | 177,500 | |
| $2.07 | -0.01 | -0.5% | $2.04 | $2.08 | $1.95 | 296,900 |
- Ticker
- Lang & Schwarz:A40LEL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 3, 2026
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Latest deck · Jul 28, 2026
Investor Presentation (July 2026)
Investor deck · 31 slides
Calls
Replays
Acasti Pharma, Inc. (ACST) Q3 2023 Earnings Call
Tue, Feb 14, 2023 · 1:00 PM ET
Watch TranscriptAcasti Pharma, Inc. (ACST) Q2 2023 Earnings Call
Mon, Nov 14, 2022 · 1:00 PM ET
Watch TranscriptAcasti Pharma, Inc. (ACST) Q1 2023 Earnings Call
Thu, Aug 11, 2022 · 1:00 PM ET
Watch Transcript
Latest news
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $2.14 (0.0%) on Sep 3, 2026
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
Aug 13, 2026
Closed $2.07 (-1.4%) on Aug 13, 2026
Grace Therapeutics Announces $10 Million Private Placement
Aug 4, 2026
Closed $2.14 (-1.8%) on Aug 5, 2026
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
Jul 28, 2026
Closed $2.25 (-2.2%) on Jul 28, 2026
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
Jun 18, 2026
Closed $2.38 (+7.2%) on Jun 18, 2026
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Apr 23, 2026
Closed $2.35 (-45.5%) on Apr 23, 2026
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Apr 14, 2026
Closed $4.28 (+12.0%) on Apr 14, 2026
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
Mar 19, 2026
Closed $4.38 (-1.4%) on Mar 19, 2026
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Feb 25, 2026
Closed $4.07 (-1.2%) on Feb 25, 2026
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
Feb 12, 2026
Closed $3.53 (-1.7%) on Feb 12, 2026
Financings
Private placement of private placement financing
Aug 13, 2026
Update: about US$10M · US$2.1 a share · Craig-Hallum
Dealers: Craig-Hallum (lead)
Use of proceeds: Support the manufacturing and regulatory work needed to advance GTx-104
Decks
Investor Presentation (July 2026)
Investor deck · 31 slides · Jul 28, 2026
Investor Presentation (April 2026)
Investor deck · 32 slides · Apr 27, 2026
Investor Presentation (2026)
Investor deck · 29 slides · 2026
Investor Presentation (November 2025)
Investor deck · 31 slides · Nov 13, 2025
Grace Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 29 in all · newest Sep 3, 2026 · oldest 2024
- Calls
- 6 calls with a replay · 6 with a transcript · latest Feb 14, 2023
- Decks
- 10 decks · latest Jul 28, 2026
Where Grace Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GRCE · Home listing | NASDAQ | United States | USD |
| BOATS:GRCE | BOATS | United States | USD |
| Lang & Schwarz:A40LEL · This page | Lang & Schwarz | Germany | EUR |
| Frankfurt:L8S | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Grace Therapeutics, Inc.